TABATHYA TALIAFERRO: Open Payments
NPI 1902218548 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$105 in 5 payments from 2 companies in 2025. Trend: 2023 $22 · 2024 $0 · 2025 $105
Food & beverage: $105
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: REXULTI, INGREZZA.
Industry payments across OK — which companies pay providers there.
